Rankings
▼
Calendar
ELVN (Enliven Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
ELVN
Enliven Therapeutics, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$104M
EPS (TTM)
-$1.83
Free Cash Flow (TTM)
-$70M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Next: Q1 2026 · Mar 12
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$16M
Q2 23
$0
$0
-$20M
Q3 23
$0
$0
-$24M
Q4 23
$0
$0
-$23M
Q1 24
$0
$0
-$26M
Q2 24
$0
$0
-$25M
Q3 24
$0
$0
-$27M
Q4 24
$0
$0
-$27M
Q1 25
$0
$0
-$32M
Q2 25
$0
$0
-$29M
Q3 25
$0
$0
-$25M
Q4 25
$0
-$46K
-$34M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$21M
-$21M
Q2 23
-$12M
-$12M
Q3 23
-$16M
-$16M
Q4 23
-$12M
-$12M
Q1 24
-$23M
-$23M
Q2 24
-$20M
-$20M
Q3 24
-$12M
-$12M
Q4 24
-$17M
-$17M
Q1 25
-$24M
-$24M
Q2 25
-$17M
-$17M
Q3 25
-$13M
-$13M
Q4 25
-$16M
-$16M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$31K
Q2 23
$88K
Q3 23
$16K
Q4 23
$14K
Q1 24
$20K
Q2 24
$2K
Q3 24
$22K
Q4 24
$0
Q1 25
$20K
Q2 25
$139K
Q3 25
$1K
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+89.2%
Q2 23
—
+123.3%
Q3 23
—
+121.8%
Q4 23
—
+123.6%
Q1 24
—
+58.3%
Q2 24
—
+22.2%
Q3 24
—
+11.6%
Q4 24
—
+18.3%
Q1 25
—
+22.0%
Q2 25
—
+16.2%
Q3 25
—
-7.3%
Q4 25
—
+27.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$2M
—
Q2 23
$4M
—
Q3 23
$3M
—
Q4 23
$3M
—
Q1 24
$5M
—
Q2 24
$5M
—
Q3 24
$5M
—
Q4 24
$5M
—
Q1 25
$7M
—
Q2 25
$8M
—
Q3 25
$7M
—
Q4 25
$12M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$12M
$5M
Q2 23
$15M
$4M
Q3 23
$20M
$3M
Q4 23
$18M
$5M
Q1 24
$20M
$6M
Q2 24
$19M
$6M
Q3 24
$21M
$6M
Q4 24
$21M
$6M
Q1 25
$25M
$7M
Q2 25
$21M
$7M
Q3 25
$18M
$7M
Q4 25
$21M
$13M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$292M
$0
$292M
Q2 23
$126M
$152M
$278M
Q3 23
$74M
$190M
$263M
Q4 23
$100M
$153M
$253M
Q1 24
$149M
$171M
$321M
Q2 24
$97M
$216M
$312M
Q3 24
$101M
$191M
$292M
Q4 24
$124M
$189M
$313M
Q1 25
$102M
$188M
$290M
Q2 25
$119M
$371M
$491M
Q3 25
$102M
$376M
$478M
Q4 25
$99M
$364M
$463M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
19M
+181.7%
Q2 23
41M
+121.2%
Q3 23
41M
+0.2%
Q4 23
41M
+0.2%
Q1 24
42M
+2.2%
Q2 24
48M
+14.3%
Q3 24
48M
+0.4%
Q4 24
50M
+3.3%
Q1 25
50M
+0.4%
Q2 25
52M
+4.1%
Q3 25
62M
+19.2%
Q4 25
57M
-8.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
$0
46
FY 24
$0
62
FY 25
$0
200K
marketcaparena.com